Triple-negative breast cancer is a highly aggressive form of breast cancer with few therapeutic options since it lacks estrogen and progesterone receptors as well as human epidermal growth factor receptor 2 (HER-2). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.